Sun Pharma gets US FDA nod for migraine treatment injection
A subsidiary of Sun Pharmaceutical Industries has received approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application to market a generic version of Sumatriptan Succinate Injection.